glp 1 medication atlanta ga GLP-1 Weight Loss Treatment in The AIM Semaglutide Program

If patients have a severe obesity-related complication including but not limited to hypertension, type 2 diabetes, CVD, dyslipidemia and a BMI of 27 mg/kg 2 or greater, then concurrent initiation of weight-loss medication with lifestyle interventions can be considered, according to the guideline

Schwartz, S

[1] GLP-3 represents a novel generation of research compounds in the anti-obesity and antidiabetic field, characterized by its unique mechanism of action involving the simultaneous activation of three metabolically relevant receptors: the GCG-like peptide-1 receptor (GLP-1R), the glucose-dependent insulinotropic polypeptide receptor (GIPR), and the GCG receptor (GCGR)

The dose conversion chart for switching back maps semaglutide doses to appropriate tirzepatide starting points

If youre within 48 hours of your scheduled dose, take it as soon as you remember, then resume your regular schedule